MLTX in the 13F filings
Moonlake Immunotherapeutics · CUSIP 61559X104
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 16 Feb 2024
- latest of these filings; the earliest 14 Feb 2024
- Managers listing it
- 7
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 5 listed it in both
- Shares listed
- 4,259,406
- combined, among listed positions
- Reported value
- $257m
- combined, at the quarter end
Among the 93 comparable managers: 6 buyers (opened or added shares) and 1 seller (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing MLTX in Q4 2023
7 of 7 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| T. Rowe Price Associates Inc | 2,314,012 | $140m | under 0.1% | Added | +196,144 | 16 Feb 2024 (the filing on sec.gov) |
| Holocene Advisors LP | 961,330 | $58m | 0.23% | Added | +855,508 | 14 Feb 2024 (the filing on sec.gov) |
| Balyasny Asset Management LLC | 598,510 | $36m | 0.07% | Added | n.a. | 14 Feb 2024 (the filing on sec.gov) |
| Schonfeld Strategic Advisors LLC | 160,400 | $9.7m | 0.06% | Trimmed | -180,300 | 14 Feb 2024 (the filing on sec.gov) |
| Woodline Partners LP | 121,754 | $7.4m | 0.08% | Added | +20,005 | 14 Feb 2024 (the filing on sec.gov) |
| Soros Fund Management LLC | 100,000 | $6.0m | 0.08% | Added | +44,000 | 14 Feb 2024 (the filing on sec.gov) |
| Farallon Capital Management LLC | 3,400 | $205k | under 0.1% | New | new | 14 Feb 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Holocene Advisors LPexisting position · 961,330 shares now+855,508
- T. Rowe Price Associates Incexisting position · 2,314,012 shares now+196,144
- Soros Fund Management LLCexisting position · 100,000 shares now+44,000
- Woodline Partners LPexisting position · 121,754 shares now+20,005
- Farallon Capital Management LLCnew position · 3,400 shares now+3,400
Reductions
- Schonfeld Strategic Advisors LLCexisting position · 160,400 shares now-180,300
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2023 | 3 | $12m | n.a. | n.a. |
| Q3 2023 | 5 | $155m | n.a. | n.a. |
| Q4 2023 | 7 | $257m | 6 | 1 |
| Q1 2024 | 4 | $116m | 3 | 3 |
| Q2 2024 | 3 | $130m | 3 | 0 |
| Q3 2024 | 4 | $300m | 3 | 1 |
| Q4 2024 | 4 | $350m | 3 | 0 |
| Q1 2025 | 3 | $44m | 1 | 2 |
| Q2 2025 | 1 | $15m | 1 | 0 |
| Q3 2025 | 1 | $6.9m | 1 | 0 |
| Q1 2026 | 2 | $75m | 14 | 13 |
| Q2 2026 | 2 | $65m | 13 | 14 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MLTX and LLY →MLTX and JNJ →MLTX and VRTX →Choose a stock to compare with MLTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MLTX, latest filings →Back to the 13F Explorer →